Infections
235
57
69
100
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
12 trials with published results (5%)
Research Maturity
100 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.9%
2 terminated out of 235 trials
98.0%
+11.5% vs benchmark
13%
31 trials in Phase 3/4
12%
12 of 100 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 100 completed trials
Clinical Trials (235)
Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections
3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia
Personalised Real-time Interoperable Sepsis Monitoring (PRISM)
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers
Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity
Analysis of the Virtual Acute Care at Home Experience
Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO)
Collection of Blood Samples for New Diagnostic Devices 2
L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)
A Cohort Study on Anti-microbial Stewardship in PICU
Assessment of the Increased Risk of Infection Following an Ultratrail
Bern, Get Ready (BEready) Cohort Study for Pandemic Preparedness
PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
Personalized Immunological Score for the Prediction of Severe Infectious Events in Immunocompromised Patients and Tailored Management (PERISCOPE)